Accession Number: | 0001237899-19-000012 |
Date: | 2019-05-13 |
Issuer: | REGENERON PHARMACEUTICALS INC (REGN) |
Original Submission Date: |
STAHL NEIL
777 OLD SAW MILL RIVER ROAD
TARRYTOWN, NY 10591
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2019-05-13 | M | 25,000 | a | $52.03 | 47,450 | direct | ||
COMMON STOCK | 2019-05-13 | F | 15,147 | d | $304.20 | 32,303 | direct | ||
COMMON STOCK | 2019-05-14 | S | 6,575 | d | $305.43 | 25,728 | direct | ||
COMMON STOCK | 2019-05-14 | S | 3,278 | d | $306.37 | 22,450 | direct | ||
COMMON STOCK | 2019-05-13 | 0 | $0.00 | 5,731 | indirect | ||||
COMMON STOCK | 2019-05-13 | 0 | $0.00 | 16,500 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) | 52.03 | 2019-05-13 | deemed execution date | M | 25,000 (d) | 2021-12-16 | common stock 25,000 | $52.03 | 98,079 | direct |
ID | footnote |
---|---|
f1 | represents volume-weighted average price of sales of 6,575 shares of company stock on may 14, 2019 at prices ranging from $305.05 to $305.98. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on may 14, 2019 at each separate price. |
f2 | represents volume-weighted average price of sales of 3,278 shares of company stock on may 14, 2019 at prices ranging from $306.00 to $306.76. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on may 14, 2019 at each separate price. |
f3 | with respect to 75,000 underlying shares, the option became exercisable on december 31, 2014, based upon the satisfaction by the company of certain performance criteria during the period ended december 31, 2014. with respect to 48,079 underlying shares, the stock option award vested in four equal annual installments, commencing one year after the date of grant. |